• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辛伐他汀所致颌骨药物相关性骨坏死(MRONJ):1例罕见病例报告

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report.

作者信息

Samieirad Sahand, Labafchi Ali, Famili Khashyar, Hashemzadeh Haleh

机构信息

Oral and maxillofacial Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Student Research Committee, Faculty of Dentistry, Mashhad University of Medical Sciences, Mashhad, Iran.

出版信息

World J Plast Surg. 2021 Jan;10(1):132-135. doi: 10.29252/wjps.10.1.132.

DOI:10.29252/wjps.10.1.132
PMID:33833966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016372/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a serious pathological condition that usually results from anti-resorptive or anti-angiogenic drugs. We aimed to report an unusual MRONJ in a female patient due to long-term simvastatin administration. A 48-year female was referred to the Department of Oral and Maxillofacial, Mashhad Dental School, Mashhad, Iran in Dec 2019. She complained of pain, swelling, and infection in the right mandibular area with a history of extraction. Based on medical history, the patient received 40 mg of simvastatin daily for ten years to control hypercholesterolemia. According to clinical and radiographic examinations, as well as previous medical and dental records, the lesion diagnosis was detected as MRONJ. Moreover, histopathological examination of the lesion confirmed our clinical diagnosis. The necrotic bone was removed with caution. The PRF was then inserted, and the flap was sutured without any tension. No complications were observed on following-up, and all symptoms were discontinued. There was a correlation between the administration of high-dose simvastatin and MRONJ. Moreover, more clinical investigation with larger sample sizes is suggested.

摘要

药物相关性颌骨坏死(MRONJ)是一种严重的病理状况,通常由抗吸收或抗血管生成药物引起。我们旨在报告一例因长期服用辛伐他汀导致的不寻常的MRONJ女性患者。一名48岁女性于2019年12月被转诊至伊朗马什哈德马什哈德牙科学院口腔颌面科。她主诉右下颌区域疼痛、肿胀及感染,有拔牙史。根据病史,该患者每日服用40毫克辛伐他汀以控制高胆固醇血症达十年。根据临床和影像学检查以及既往医疗和牙科记录,病变诊断为MRONJ。此外,病变的组织病理学检查证实了我们的临床诊断。小心地清除坏死骨。然后植入富血小板纤维蛋白(PRF),并在无张力情况下缝合皮瓣。随访期间未观察到并发症,所有症状均消失。高剂量辛伐他汀的使用与MRONJ之间存在关联。此外,建议进行更大样本量的更多临床研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6111/8016372/b6eeb8fc4cf8/wjps-10-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6111/8016372/a459ef4e07f0/wjps-10-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6111/8016372/b6eeb8fc4cf8/wjps-10-132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6111/8016372/a459ef4e07f0/wjps-10-132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6111/8016372/b6eeb8fc4cf8/wjps-10-132-g002.jpg

相似文献

1
Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report.辛伐他汀所致颌骨药物相关性骨坏死(MRONJ):1例罕见病例报告
World J Plast Surg. 2021 Jan;10(1):132-135. doi: 10.29252/wjps.10.1.132.
2
Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies.不同原发性癌症及药物治疗相关颌骨骨坏死(MRONJ)的影像学评估
Cureus. 2023 Aug 1;15(8):e42830. doi: 10.7759/cureus.42830. eCollection 2023 Aug.
3
Tocilizumab: Another medication related to osteonecrosis of the jaws? A case report and literature review.托珠单抗:另一种与颌骨坏死相关的药物?一例病例报告及文献综述。
GMS Interdiscip Plast Reconstr Surg DGPW. 2021 Apr 14;10:Doc03. doi: 10.3205/iprs000153. eCollection 2021.
4
Spontaneous Healing of Mandibular Noncontinuous Defect Caused by Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死所致下颌骨非连续性缺损的自发愈合
J Craniofac Surg. 2016 Jun;27(4):e390-2. doi: 10.1097/SCS.0000000000002665.
5
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
6
The use of Platelet-rich Fibrin in the management of medication-related osteonecrosis of the jaw: A case series.富血小板纤维蛋白在药物相关性颌骨坏死中的应用:一项病例系列研究。
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89. doi: 10.1016/j.jormas.2019.02.011. Epub 2019 Feb 20.
7
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?影响接受大剂量双膦酸盐或地舒单抗治疗的癌症患者药物相关性颌骨坏死发展的因素:拔牙是否为危险因素?
PLoS One. 2018 Jul 26;13(7):e0201343. doi: 10.1371/journal.pone.0201343. eCollection 2018.
8
Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals.不同健康专业人员对药物相关性颌骨坏死的认识。
Support Care Cancer. 2020 Nov;28(11):5397-5404. doi: 10.1007/s00520-020-05374-4. Epub 2020 Mar 6.
9
A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats.一项关于20只猫双膦酸盐相关颌骨坏死的回顾性病例系列研究。
Front Vet Sci. 2024 Aug 23;11:1436988. doi: 10.3389/fvets.2024.1436988. eCollection 2024.
10
Fatal Bleeding in Conjunction with Mandibular Medication-related Osteonecrosis of the Jaw (MRONJ).与下颌骨药物相关性骨坏死(MRONJ)相关的致命性出血
Bull Tokyo Dent Coll. 2018;59(1):27-34. doi: 10.2209/tdcpublication.2016-0052.

引用本文的文献

1
Comprehensive Review of Prevention and Management Strategies for Medication-related Osteonecrosis of the Jaw (MRONJ).颌骨药物性骨坏死(MRONJ)预防与管理策略的综合综述
Oral Health Prev Dent. 2025 Aug 5;23:403-417. doi: 10.3290/j.ohpd.c_2169.
2
Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy.病例报告:单剂量低剂量地诺单抗引发双膦酸盐治疗后骨质疏松症患者发生下颌骨坏死性骨炎。
Front Oral Health. 2024 Dec 4;5:1473049. doi: 10.3389/froh.2024.1473049. eCollection 2024.
3
Secukinumab Causing Medication-Related Osteonecrosis of the Jaw, in a Patient Diagnosed with Psoriasis and Rheumatoid Arthritis.

本文引用的文献

1
Accessory Mental Foramen in a Patient with Mandibular Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) Lesion: A Case Report.一名患有下颌双膦酸盐相关颌骨坏死(BRONJ)病变患者的副颏孔:病例报告
World J Plast Surg. 2020 Jan;9(1):92-98. doi: 10.29252/wjps.9.1.92.
2
Medication-related Osteonecrosis of the Jaw: A Review.药物相关性颌骨坏死:综述
Cureus. 2020 Feb 10;12(2):e6944. doi: 10.7759/cureus.6944.
3
Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review.
司库奇尤单抗导致一名诊断为银屑病和类风湿关节炎患者的药物相关性颌骨坏死。
Psoriasis (Auckl). 2024 Sep 23;14:115-120. doi: 10.2147/PTT.S490982. eCollection 2024.
4
Medication-Related Osteonecrosis of the Jaw: A Systematic Review of Case Reports and Case Series.药物相关性颌骨坏死:病例报告与病例系列的系统评价
Diseases. 2024 Sep 9;12(9):205. doi: 10.3390/diseases12090205.
5
Two Cases of COVID-Related Osteonecrosis of the Jaws: A New and Worrying Entity Is Emerging.两例与新冠病毒相关的颌骨骨坏死:一种新的且令人担忧的病症正在出现。
World J Plast Surg. 2024;13(1):96-102. doi: 10.61186/wjps.13.1.96.
血小板浓缩物在预防和治疗药物相关性颌骨坏死中的应用是否有效?系统评价。
J Craniomaxillofac Surg. 2020 Mar;48(3):268-285. doi: 10.1016/j.jcms.2020.01.014. Epub 2020 Feb 3.
4
Medication-Related Osteonecrosis of the Jaw in Patients Taking High-Dose Simvastatin.服用大剂量辛伐他汀患者的药物相关性颌骨坏死
J Oral Maxillofac Surg. 2020 Jun;78(6):862-863. doi: 10.1016/j.joms.2020.01.009. Epub 2020 Jan 20.
5
Review and update on drugs related to the development of osteonecrosis of the jaw.药物相关性颌骨骨坏死的研究进展与更新。
Med Oral Patol Oral Cir Bucal. 2020 Jan 1;25(1):e71-e83. doi: 10.4317/medoral.23191.
6
The impact of simvastatin intervention on the healing of bone, soft tissue, and TMJ cartilage in dentistry: a systematic review and meta-analysis.辛伐他汀干预对牙科领域骨组织、软组织及颞下颌关节软骨愈合的影响:一项系统评价与荟萃分析
Int J Implant Dent. 2019 Apr 9;5(1):17. doi: 10.1186/s40729-019-0168-4.
7
Medication-related osteonecrosis of the jaw: Clinical and practical guidelines.药物相关性颌骨坏死:临床与实践指南
J Int Soc Prev Community Dent. 2016 Mar-Apr;6(2):97-104. doi: 10.4103/2231-0762.178742.
8
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.
9
The role of topical simvastatin on bone regeneration: A systematic review.局部用辛伐他汀对骨再生的作用:一项系统评价。
J Clin Exp Dent. 2014 Jul 1;6(3):e286-90. doi: 10.4317/jced.51415. eCollection 2014 Jul.
10
Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes.辛伐他汀抑制地塞米松诱导的人骨髓脂肪细胞纤溶酶原激活物抑制剂-1的分泌。
BMC Musculoskelet Disord. 2011 Apr 27;12(1):82. doi: 10.1186/1471-2474-12-82.